Leonid Karawajew

3.7k total citations
82 papers, 2.4k citations indexed

About

Leonid Karawajew is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Leonid Karawajew has authored 82 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 35 papers in Public Health, Environmental and Occupational Health and 30 papers in Hematology. Recurrent topics in Leonid Karawajew's work include Acute Lymphoblastic Leukemia research (35 papers), Acute Myeloid Leukemia Research (23 papers) and Cell death mechanisms and regulation (11 papers). Leonid Karawajew is often cited by papers focused on Acute Lymphoblastic Leukemia research (35 papers), Acute Myeloid Leukemia Research (23 papers) and Cell death mechanisms and regulation (11 papers). Leonid Karawajew collaborates with scholars based in Germany, Austria and Italy. Leonid Karawajew's co-authors include Christian Wuchter, Richard Ratei, Wolfgang Ludwig, Bernd Dörken, Martin Schrappe, V Ruppert, Peter Rhein, W-D Ludwig, Michael Dworzak and Burkhard Micheel and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Leonid Karawajew

79 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leonid Karawajew Germany 30 1.1k 882 828 573 499 82 2.4k
Jean‐Pierre Bourquin Switzerland 34 2.0k 1.8× 1.1k 1.3× 1.3k 1.6× 889 1.6× 522 1.0× 129 3.9k
N Feller Netherlands 21 975 0.9× 302 0.3× 1.1k 1.3× 1.2k 2.1× 413 0.8× 56 2.5k
Maher Abdul‐Hay United States 13 1.0k 0.9× 568 0.6× 1.0k 1.3× 564 1.0× 396 0.8× 42 2.3k
Francis Lacombe France 28 948 0.9× 393 0.4× 952 1.1× 448 0.8× 418 0.8× 82 2.4k
Jerrold Fried United States 26 983 0.9× 261 0.3× 525 0.6× 428 0.7× 238 0.5× 60 2.1k
Seth J. Corey United States 35 1.4k 1.3× 126 0.1× 996 1.2× 850 1.5× 1.1k 2.1× 114 3.5k
Jeremy A. Ross United States 22 1.2k 1.1× 140 0.2× 871 1.1× 622 1.1× 406 0.8× 91 2.0k
Didier Grillot United States 26 1.5k 1.4× 253 0.3× 286 0.3× 634 1.1× 976 2.0× 39 2.7k
Emanuela Colombo Italy 23 2.1k 1.9× 161 0.2× 980 1.2× 545 1.0× 253 0.5× 37 2.7k
Ingo Tamm Germany 21 2.7k 2.4× 199 0.2× 355 0.4× 980 1.7× 541 1.1× 42 3.4k

Countries citing papers authored by Leonid Karawajew

Since Specialization
Citations

This map shows the geographic impact of Leonid Karawajew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonid Karawajew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonid Karawajew more than expected).

Fields of papers citing papers by Leonid Karawajew

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonid Karawajew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonid Karawajew. The network helps show where Leonid Karawajew may publish in the future.

Co-authorship network of co-authors of Leonid Karawajew

This figure shows the co-authorship network connecting the top 25 collaborators of Leonid Karawajew. A scholar is included among the top collaborators of Leonid Karawajew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonid Karawajew. Leonid Karawajew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chitadze, Guranda, et al.. (2022). A New View on Minimal Residual Disease Quantification in Acute Lymphoblastic Leukemia using Droplet Digital PCR. Journal of Molecular Diagnostics. 24(8). 856–866. 6 indexed citations
2.
Reiter, Michael J., Margarita Maurer‐Granofszky, Angela Schumich, et al.. (2022). Automated identification of cell populations in flow cytometry data with transformers. Computers in Biology and Medicine. 144. 105314–105314. 12 indexed citations
3.
Groeneveld‐Krentz, Stefanie, M. Schroeder, Michael J. Reiter, et al.. (2019). Aneuploidy in children with relapsed B‐cell precursor acute lymphoblastic leukaemia: clinical importance of detecting a hypodiploid origin of relapse. British Journal of Haematology. 185(2). 266–283. 16 indexed citations
4.
Rhein, Peter, Martin Zimmermann, Obul Reddy Bandapalli, et al.. (2013). High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol. Haematologica. 99(1). 103–110. 24 indexed citations
6.
Kirschner‐Schwabe, Renate, Claudio Lottaz, Peter Rhein, et al.. (2006). Expression of Late Cell Cycle Genes and an Increased Proliferative Capacity Characterize Very Early Relapse of Childhood Acute Lymphoblastic Leukemia. Clinical Cancer Research. 12(15). 4553–4561. 32 indexed citations
9.
Wuchter, Christian, Daniel Krappmann, Zhen Cai, et al.. (2001). In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-κB activity. Leukemia. 15(6). 921–928. 63 indexed citations
11.
Ratei, Richard, Christian Sperling, Leonid Karawajew, et al.. (1998). Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia. Annals of Hematology. 77(3). 107–114. 49 indexed citations
12.
Beltinger, Christian, Thomas Böhler, Leonid Karawajew, et al.. (1998). Mutation analysis of CD95 (APO‐1/Fas) in childhood B‐lineage acute lymphoblastic leukaemia. British Journal of Haematology. 102(3). 722–728. 27 indexed citations
14.
Karawajew, Leonid, et al.. (1994). A flow cytometric long-term cytotoxicity assay. Journal of Immunological Methods. 177(1-2). 119–130. 18 indexed citations
15.
Jantscheff, Peter, et al.. (1993). Hybrid hybridomas producing bispecific antibodies to CEA and peroxidase isolated by a combination of HAT medium selection and fluorescence activated cell sorting. Journal of Immunological Methods. 163(1). 91–97. 22 indexed citations
16.
Behrsing, Olaf, et al.. (1992). Bispecific IgA/IgM antibodies and their use in enzyme immunoassay. Journal of Immunological Methods. 156(1). 69–77. 7 indexed citations
17.
Karawajew, Leonid, et al.. (1988). Production and ELISA application of bispecific monoclonal antibodies against fluorescein isothiocyanate (FITC) and horseradish peroxidase (HRP). Journal of Immunological Methods. 111(1). 95–99. 41 indexed citations
18.
Karawajew, Leonid & Bernhard Schlott. (1986). Single step isolation of immunofluorescence-stained, viable lymphocytes by fluorescence-activated cell sorter using ethidium bromide.. PubMed. 45(5). K1–3. 1 indexed citations
19.
B�ttger, M., et al.. (1982). Physicochemical properties of salt-soluble, unsheared chromatin. Molecular Biology Reports. 8(3). 137–142. 3 indexed citations
20.
Karawajew, Leonid, et al.. (1981). Ionic strength dependent structural changes of nucleosomes.. PubMed. 40(2). 105–14. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026